# Relative Bioavailability Study to Evaluate Cetirizine HCl Gummy 10 mg and Cetirizine HCl Oral Tablets 10 mg

> **NCT04071821** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Seattle Gummy Company** · enrollment: 30 (estimated)

## Conditions studied

- Allergy

## Interventions

- **DRUG:** cetirizine HCl Gummy
- **DRUG:** Zyrtec tablet 10mg

## Key facts

- **NCT ID:** NCT04071821
- **Lead sponsor:** Seattle Gummy Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2025-07-15
- **Final completion:** 2025-09-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04071821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04071821, "Relative Bioavailability Study to Evaluate Cetirizine HCl Gummy 10 mg and Cetirizine HCl Oral Tablets 10 mg". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04071821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*